Advances in the Frontline Treatment of Multiple Myeloma
 |
|

Amitabha Mazumder, MD, reviews the integration of novel agents into the frontline treatment of ASCT-eligible and ASCT-ineligible multiple myeloma patients.
Format: Microsoft PowerPoint (.ppt) | File size: 959 KB | Date posted: 6/26/2008
Slide topics include:
|
Browse Slides by Date - Descending
EGFR-Targeted Antibodies: Clinical Applications, Treatment Challenges, and Ongoing Scientific Research
 |
|

David Cunningham, MD, FRCP discusses the rationale for targeting the EGFR with monoclonal antibodies and gives an update on their use in gastrointestinal cancers as monotherapy and in combination with chemotherapies.
Format: Microsoft PowerPoint (.ppt) | File size: 6,534 KB | Date posted: 6/12/2008
Slide topics include:
|
Targeting the Tumor Microenvironment: Ongoing Research, Clinical Updates and Promising Applications
 |
|

Allan Lipton, MD, reviews current and emerging management strategies for cancer patients with bone metastases.
Format: Microsoft PowerPoint (.ppt) | File size: 1,568 KB | Date posted: 6/12/2008
Slide topics include:
|
Multitargeted Tyrosine Kinase Inhibitors: Clinical Advances, Synergistic Approaches, and Future Development
 |
|

Ezra Cohen MD, FRCPC, gives an update on the use of multitargeted tyrosine kinase inhibitors approved for the treatment of a variety of cancers, and provides an overview of mTKIs in clinical development.
Format: Microsoft PowerPoint (.ppt) | File size: 2,132 KB | Date posted: 6/12/2008
Slide topics include:
|
Targeting Multiple Pathways in the Treatment of Cancer
 |
|

Manuel Hidalgo, MD, PhD, gives a brief overview of the current state-of-the-art with monoclonal antibodies and multitargeted tyrosine kinase inhibitors as antitumor therapies.
Format: Microsoft PowerPoint (.ppt) | File size: 2,047 KB | Date posted: 6/12/2008
Slide topics include:
|
New Agents for the Management of Ovarian Cancer
 |
|

Downloadable slidesets on new agents in development for recurrent ovarian cancer patients
Format: Microsoft PowerPoint (.ppt) | File size: 2,187 KB | Date posted: 5/2/2008
Slide topics include:
|
Current Controversies in the Management of Recurrent Ovarian Cancer
 |
|

Downloadable slidesets on controversial topics and treatment approaches for managing recurrent ovarian cancer patients
Format: Microsoft PowerPoint (.ppt) | File size: 410 KB | Date posted: 4/29/2008
Slide topics include:
|
Current Hormonal Therapy Strategies for ER-Positive Postmenopausal Breast Cancer
 |
|

Downloadable slideset reviews the clinical management of postmenopausal patients with early breast cancer receiving hormonal therapy
Format: Microsoft PowerPoint (.ppt) | File size: 717 KB | Date posted: 4/24/2008
Slide topics include:
|
The Role of Predictive Factors in Guiding Treatment Decisions for ER-Positive Postmenopausal Breast Cancer
 |
|

Downloadable slideset focused on predictive factors and prognostic assays used to stratify postmenopausal patients with early breast cancer to help guide treatment decisions.
Format: Microsoft PowerPoint (.ppt) | File size: 2,286 KB | Date posted: 4/24/2008
Slide topics include:
|
Evaluating Long-Term Safety of Aromatase Inhibitors
 |
|

Downloadable slideset focused on the long-term safety issues associated with the use of tamoxifen and aromatase inhbitors
Format: Microsoft PowerPoint (.ppt) | File size: 5,299 KB | Date posted: 4/23/2008
Slide topics include:
|
Chronic Myeloid Leukemia
 |
|

Neil Shah, MD, PhD, discusses recent data on current and novel therapeutic approaches for treating patients with chronic myeloid leukemia.
Format: Microsoft PowerPoint (.ppt) | File size: 1,210 KB | Date posted: 4/22/2008
Slide topics include:
|
|

Use the following filters to quickly browse and download slides for your talks
Browse slides by:
All Slides by Date (249)
Program Type
Topic
Featured Content
Multidisciplinary management of liver metastases in CRC, applying the latest data in practice.
Access Capsule Summaries and Expert Highlights from the 2008 oncology meeting.
Text, presentations, and slides providing the latest insights from top experts.
|